Safety of Moxifloxacin following repeated intramuscular administration in Wistar rats
Moxifloxacin is a novel fourth generation fluoroquinolone with broad spectrum of antibacterial activity. The study was conducted to evaluate the safety of Moxifloxacin (5.0 mg/kg) after repeated intramuscular administration at 24 h interval for 14 days in male and female wistar rats. Hematological (...
Main Authors: | K.A. Sadariya, A.K. Gothi, S.D. Patel, S.K. Bhavsar and A.M. Thaker |
---|---|
Format: | Article |
Language: | English |
Published: |
Veterinary World
2010-01-01
|
Series: | Veterinary World |
Subjects: | |
Online Access: | http://www.scopemed.org/mnstemps/2/2-1286564526.pdf |
Similar Items
-
Effect of moxifloxacin administration on pharmacokinetics of tolfenamic acid in rats
by: Satish D. Patel, et al.
Published: (2011-08-01) -
A Case Report of Severe Corneal Toxicity following 0.5% Topical Moxifloxacin Use
by: A.P. Vignesh, et al.
Published: (2015-02-01) -
The effectiveness of moxifloxacin in the treatment of community-acquired pneumonia
by: Dmytro Dmytriiev, et al.
Published: (2021-11-01) -
Moxifloxacin Induced Seizures -A Case Report.
by: Jiana Shi, et al.
Published: (2014-09-01) -
Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA
by: Lisa Trieu, et al.
Published: (2015-03-01)